Novel small molecule activators of the Trk family of receptor tyrosine kinases

► The neurotrophic Trk receptor family and their drug target potential are reviewed. ► Supplementation of endogenous ligand is an ineffective therapeutic. ► Various approaches used to generate ligand mimetics are discussed. ► Characteristics and therapeutic efficacy of agonistic molecules are summarized.